hotspot -WSS

hotspot

author：Wikipedia 2025-10-01 23:07:15 - browse：65141

Without question, the new federal law banning surprise billing is achieving its goal of protecting patients from enormous medical bills. But in doing so, the measure, which was initially projected to lower federal spending, appears to be raising costs elsewhere.

The Biden administration’s new progress report on the process for arbitrating disagreements between insurance companies and providers, which covers the first six months of 2023, shows that in over 80% of payment disputes, the arbiter settled on an amount that was more than the median in-network rate for that service. In other words, insurers were ordered to pay more to an out-of-network provider than they’d pay to a contracted one. Not only that, the sheer volume of disputes means the three federal agencies that run the program are devoting much more time to it than expected.

“It raises concerns for folks that envisioned the arbitration process as helping to moderate costs rather than be a tool these companies can leverage to obtain even higher payments,” said Zachary Baron, the director of Georgetown University’s Health Policy and Law Initiative.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
Next article： Schizophrenia gene found to be linked to cells' energy dysfunction

Wikipedia

WSS

Senators push IRS to launch nonprofit hospital probe

AstraZeneca chief proposes a novel edit to the drug pricing bill

Illumina names Agilent executive as new CEO

Patients, digital health players weigh in on FTC's data privacy plan

How generative AI is inspiring dreams of a health data revolution

Snackable artificial intelligence, expert AI, and the pharma industry

explore

hotspot

focus

State Dept. review finds Biden bears some blame for Afghanistan failures

Montana youths win climate lawsuit against state for promoting fossil fuels

Apple is now the first public company to be valued at $3 trillion

Judge sides with young activists in first

How one medical school became remarkably diverse

Dozens dead from Maui wildfires: What we know about the victims

DIEP, the 'gold standard' of breast reconstruction, is under threat

What to know about the judge who will handle the Trump case

Heart attack and stroke risk calculators need revising

Amazon on where the company's health care bets are headed next

leisure time

Stem cell treatment guidelines are released by FDA

Schizophrenia gene found to be linked to cells' energy dysfunction

Mark Cuban is blaming the wrong people for high drug costs

Snackable artificial intelligence, expert AI, and the pharma industry

Treatments for cramps don't cut it. Why aren't there better options?

Biogen’s boardroom scandal saddles CEO with first crisis

focus

hotspot

Wikipedia

leisure time